Skip to main content

Table 2 Comparison of SPP and ABI lower and higher group in HD patients

From: Skin perfusion pressure predicts mortality in hemodialysis patients: long term follow-up

  SPP <70 SPP ≥70    ABI <1.15 ABI ≥1.15  
(n = 22) (n = 23) p value (n = 23) (n = 22) p value
Gender (male to female) 13:09 18:05   Gender (male to female) 15:08 16:06  
Age (years) 66.8 ± 14.5 58.7 ± 8.8 0.04 Age (years) 68.0 ± 11.4 57.7 ± 11.5 0.01
HD duration (years) 8.1 ± 6.1 6.6 ± 4.0 0.32 HD duration (years) 8.3 ± 6.2 6.4 ± 3.9 0.56
DM, n (%) 10 (59.0%) 7 (41.0%) 0.31 DM, n (%) 11 (64.7) 6 (53.3) 0.09
Current smoking, n (%) 3 (60.0%) 2 (40.0%) 0.91 Current smoking, n (%) 4 (60.0%) 1 (40.0%) 0.91
Statin, n (%) 3 (60.0%) 2 (40.0%) 0.65 Statin, n (%) 3 (60.0%) 2 (40.0%) 0.66
Cilostazol, n (%) 3 (75.0%) 1 (25.0%) 0.46 Cilostazol, n (%) 3 (75.0%) 1 (25.0%) 0.44
Hb (g/dl) 10.2 ± 1.0 10.0 ± 1.0 0.62 Hb (g/dl) 10.2 ± 0.9 10.0 ± 1.0 0.62
Alb (g/dl) 4.1 ± 0.4 4.2 ± 0.3 0.39 Alb (g/dl) 4.1 ± 0.3 4.1 ± 0.5 0.39
BUN (mg/dl) 68.5 ± 12.1 70.1 ± 12.5 0.65 BUN (mg/dl) 66.9 ± 12.4 71.6 ± 11.8 0.19
Cr (mg/dl) 10.3 ± 1.9 12.0 ± 2.1 0.01 Cr (mg/dl) 10.8 ± 2.1 11.4 ± 2.2 0.38
P (mg/dl) 4.9 ± 1.2 5.2 ± 1.2 0.43 P (mg/dl) 5.1 ± 1.1 5.1 ± 1.3 0.94
i-PTH (pg/dl) 170.4 ± 93.5 182.0 ± 129.7 0.71 i-PTH (pg/dl) 213.1 ± 134.8 142.3 ± 74.4 0.03
LVDd (mm) 50.5 ± 5.1 51.8 ± 5.1 0.41 LVDd (mm) 50.9 ± 4.7 51.4 ± 5.4 0.71
LVEF (%) 64.6 ± 7.1 68.5 ± 10.2 0.15 LVEF (%) 64.6 ± 9.3 68.6 ± 8.4 0.14